Wisconsin Bio News

10Jun 2020

Read the full press release from Catalent here. Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has signed an agreement with Spicona, Inc. to develop a virus-like protein (VLP)-based vaccine against COVID-19. Under the terms […]

05Jun 2020

Read the full story from the Wisconsin State Journal here. A Madison-based pharmaceutical developer looking to address the opioid crisis won the Wisconsin Governor’s Business Plan Contest Thursday. Plumb Pharmaceuticals, which is developing a drug delivery method that will help people battling opioid addiction, will receive cash and in-kind services for winning the grand prize […]

04Jun 2020

Read the full story from WISBUSINESS here. Virologists at the Morgridge Institute for Research are investigating the biology of viruses and their diseases in order to develop powerful new methods to not only control COVID-19 but stem the next pandemic. According to the institute, COVID-19 illustrates how viral threats are growing more common, underscoring the […]

02Jun 2020

Read the full press release from the Wisconsin Alumni Research Foundation here. $100K fund to accelerate solutions being developed by UW–Madison researchers MADISON, Wis. – The Wisconsin Alumni Research Foundation announced that nine highly deployable projects have been selected to receive development funding through the UW/WARF COVID-19 Accelerator Challenge. From improved respirators to accelerated testing, […]

11May 2020

Read the full press release from SHINE Medical Technologies here. SHINE Medical Technologies LLC today announced that the U.S. Nuclear Regulatory Commission (NRC) expects to make a final determination regarding the issuance of an operating license to SHINE by October 2021. SHINE’s application for a license to operate the medical isotope production facility that it […]

10May 2020

Read the full story from the Wisconsin State Journal here. A Madison-based diagnostics company wants to make testing for the COVID-19 coronavirus easier and quicker for patients and health care providers. GoDx has been developing paper-based tests for pathogens that cause gastrointestinal diseases, such as salmonella and norovirus. While those tests are currently undergoing clinical […]

07May 2020

Read the full story from WISCONSININNO. Madison-based Nimble Therapeutics, a fairly new company that was spun out from Switzerland-based F. Hoffmann-La Roche, is collaborating with Roche Diagnostics to discover and develop novel peptide-based molecules for diagnostics of SARS-CoV-2, the virus that causes COVID-19. Nimble Therapeutics is developing a chemical synthesis technology for drug development. The […]

04May 2020

Read the full story from BizTimes here. A potential single shot COVID-19 vaccine will be produced at Catalent, Inc.’s biomanufacturing facility in Madison. Somerset, New Jersey-based Catalent and San Diego-based Arcturus Therapeutics Holdings Inc. announced Monday they are partnering to manufacture a COVID-19 mRNA vaccine candidate. The LUNAR-COV19 vaccine will be produced at Catalent Biologics’ […]

27Apr 2020

Read the full story from Olean Times Herald here. Gilson and QIAGEN have entered into a strategic partnership that will provide researchers the ability to limit operator-dependent variation in their manual nucleic acid extraction results and improve the traceability of their workflows. This agreement brings together two influential leaders in the life science industries: Gilson, […]